REG-BARCLAYS PLC FORM 8.3 - STERIS CORPORATION <Origin Href="QuoteRef">BARC.L</Origin> <Origin Href="QuoteRef">STE.N</Origin>
FORM 8.3 - STERIS CORPORATION
FORM 8.3
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY
A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
Rule 8.3 of the Takeover Code (the Code)
1. KEY INFORMATION
| (a) | Full name of discloser: | Barclays PLC. | |||
| (b) | Owner or controller of interest and short | ||||
| positions disclosed, if different from 1(a): | |||||
| (c) | Name of offeror/offeree in relation to whose | STERIS CORPORATION | |||
| relevant securities this form relates: | |||||
| (d) | If an exempt fund manager connected with an | ||||
| offeror/offeree, state this and specify identity of | |||||
| offeror/offeree: | |||||
| (e) | Date position held/dealing undertaken: | 23 October 2015 | |||
| (f) | In addition to the company in 1(c) above, is the discloser making | YES: | |||
| disclosures in respect of any other party to the offer? | SYNERGY HEALTH PLC |
2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE
If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.
(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)
| Class of relevant security: | ORD | ||||||||||
| Interests | Short Positions | ||||||||||
| Number | (%) | Number | (%) | ||||||||
| (1) | Relevant securities owned | ||||||||||
| and/or controlled: | 118,006 | 0.20% | 287,814 | 0.48% | |||||||
| (2) | Cash-settled derivatives: | ||||||||||
| 284,112 | 0.47% | 0 | 0.00% | ||||||||
| (3) | Stock-settled derivatives (including options) | ||||||||||
| and agreements to purchase/sell: | 0 | 0.00% | 0 | 0.00% | |||||||
| TOTAL: | 402,118 | 0.67% | 287,814 | 0.48% | |||||||
All interests and all short positions should be disclosed.
Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form8 (Open Positions).
(b) Rights to subscribe for new securities (including directors and other employee options)
| Class of relevant security in relation to which subscription right exists: | |
| Details, including nature of the rights concerned and relevant percentages: |
3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE
Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.
The currency of all prices and other monetary amounts should be stated.
(a) Purchases and sales
| Class of relevant | Purchase/sale | Number of | Price per unit | ||||
| security | securities | ||||||
| ORD | Purchase | 20 | 68.5700 USD | ||||
| ORD | Purchase | 40 | 68.6600 USD | ||||
| ORD | Purchase | 78 | 67.4300 USD | ||||
| ORD | Purchase | 78 | 68.2597 USD | ||||
| ORD | Purchase | 100 | 68.0200 USD | ||||
| ORD | Purchase | 100 | 68.5500 USD | ||||
| ORD | Purchase | 100 | 68.2200 USD | ||||
| ORD | Purchase | 100 | 67.7600 USD | ||||
| ORD | Purchase | 100 | 67.7200 USD | ||||
| ORD | Purchase | 100 | 68.2700 USD | ||||
| ORD | Purchase | 100 | 68.2100 USD | ||||
| ORD | Purchase | 100 | 68.4100 USD | ||||
| ORD | Purchase | 156 | 67.6850 USD | ||||
| ORD | Purchase | 158 | 68.2415 USD | ||||
| ORD | Purchase | 200 | 68.5750 USD | ||||
| ORD | Purchase | 200 | 68.2450 USD | ||||
| ORD | Purchase | 299 | 68.2070 USD | ||||
| ORD | Purchase | 370 | 68.2735 USD | ||||
| ORD | Purchase | 605 | 68.1700 USD | ||||
| ORD | Purchase | 700 | 68.3418 USD | ||||
| ORD | Purchase | 817 | 68.0108 USD | ||||
| ORD | Purchase | 900 | 68.1611 USD | ||||
| ORD | Purchase | 1,000 | 68.1210 USD | ||||
| ORD | Purchase | 1,100 | 68.2261 USD | ||||
| ORD | Purchase | 1,100 | 68.2636 USD | ||||
| ORD | Purchase | 1,200 | 67.5425 USD | ||||
| ORD | Purchase | 1,400 | 68.2185 USD | ||||
| ORD | Purchase | 1,576 | 68.1713 USD | ||||
| ORD | Purchase | 2,200 | 68.3986 USD | ||||
| ORD | Purchase | 2,300 | 68.1098 USD | ||||
| ORD | Purchase | 2,300 | 68.4304 USD | ||||
| ORD | Purchase | 2,399 | 68.2411 USD | ||||
| ORD | Purchase | 3,200 | 67.9546 USD | ||||
| ORD | Purchase | 3,907 | 68.3210 USD | ||||
| ORD | Purchase | 4,400 | 68.1505 USD | ||||
| ORD | Purchase | 5,104 | 68.4265 USD | ||||
| ORD | Purchase | 5,976 | 68.1609 USD | ||||
| ORD | Purchase | 8,749 | 68.3111 USD | ||||
| ORD | Purchase | 10,890 | 68.0565 USD | ||||
| ORD | Purchase | 16,000 | 68.2745 USD | ||||
| ORD | Purchase | 19,500 | 68.2343 USD | ||||
| ORD | Purchase | 29,100 | 68.3439 USD | ||||
| ORD | Purchase | 31,000 | 68.3203 USD | ||||
| ORD | Purchase | 58,216 | 68.1928 USD | ||||
| ORD | Purchase | 66,305 | 68.3419 USD | ||||
| ORD | Sale | 1 | 68.1100 USD | ||||
| ORD | Sale | 40 | 68.6600 USD | ||||
| ORD | Sale | 96 | 68.0400 USD | ||||
| ORD | Sale | 100 | 67.7200 USD | ||||
| ORD | Sale | 100 | 68.4500 USD | ||||
| ORD | Sale | 100 | 67.6100 USD | ||||
| ORD | Sale | 100 | 68.3100 USD | ||||
| ORD | Sale | 100 | 68.3200 USD | ||||
| ORD | Sale | 100 | 68.4100 USD | ||||
| ORD | Sale | 100 | 67.9200 USD | ||||
| ORD | Sale | 198 | 68.0667 USD | ||||
| ORD | Sale | 199 | 68.1602 USD | ||||
| ORD | Sale | 200 | 68.2700 USD | ||||
| ORD | Sale | 209 | 68.0070 USD | ||||
| ORD | Sale | 211 | 67.8489 USD | ||||
| ORD | Sale | 249 | 67.7500 USD | ||||
| ORD | Sale | 302 | 68.2877 USD | ||||
| ORD | Sale | 400 | 68.3312 USD | ||||
| ORD | Sale | 401 | 68.4137 USD | ||||
| ORD | Sale | 403 | 67.7800 USD | ||||
| ORD | Sale | 500 | 67.8878 USD | ||||
| ORD | Sale | 550 | 68.2455 USD | ||||
| ORD | Sale | 750 | 68.1936 USD | ||||
| ORD | Sale | 800 | 68.4387 USD | ||||
| ORD | Sale | 902 | 67.7994 USD | ||||
| ORD | Sale | 1,200 | 67.5425 USD | ||||
| ORD | Sale | 1,300 | 68.1267 USD | ||||
| ORD | Sale | 1,333 | 68.2147 USD | ||||
| ORD | Sale | 1,500 | 68.4026 USD | ||||
| ORD | Sale | 1,835 | 68.2192 USD | ||||
| ORD | Sale | 2,400 | 68.3935 USD | ||||
| ORD | Sale | 2,900 | 68.2589 USD | ||||
| ORD | Sale | 3,290 | 68.2271 USD | ||||
| ORD | Sale | 3,295 | 68.2052 USD | ||||
| ORD | Sale | 3,400 | 68.1080 USD | ||||
| ORD | Sale | 3,531 | 68.1961 USD | ||||
| ORD | Sale | 3,800 | 68.3568 USD | ||||
| ORD | Sale | 5,849 | 68.1869 USD | ||||
| ORD | Sale | 5,850 | 68.1610 USD | ||||
| ORD | Sale | 6,102 | 68.1609 USD | ||||
| ORD | Sale | 6,389 | 68.3108 USD | ||||
| ORD | Sale | 6,500 | 68.2141 USD | ||||
| ORD | Sale | 7,050 | 68.1736 USD | ||||
| ORD | Sale | 7,300 | 68.3239 USD | ||||
| ORD | Sale | 7,700 | 68.2773 USD | ||||
| ORD | Sale | 8,093 | 68.1076 USD | ||||
| ORD | Sale | 10,424 | 68.1589 USD | ||||
| ORD | Sale | 17,100 | 68.3620 USD | ||||
| ORD | Sale | 18,200 | 68.2420 USD | ||||
| ORD | Sale | 26,232 | 68.2347 USD |
(b) Cash-settled derivative transactions
| Class of relevant security | Product description e.g. CFD | Nature of dealing e.g. opening/closing a long/short position, increasing/reducing a long/short position | Number of reference securities | Price per unit |
(c) Stock-settled derivative transactions (including options)
(i) Writing, selling, purchasing or varying
| Class of relevant security | Product description e.g. call option | Writing, purchasing, selling, varying etc. | Number of securities to which option relates | Exercise price per unit | Type e.g. American, European etc. | Expiry date | Option money paid/ received per unit |
(ii) Exercise
| Class of relevant security | Product description e.g. call option | Exercising/ exercised against | Number of securities | Exercise price per unit |
(d) Other dealings (including subscribing for new securities)
| Class of relevant security | Nature of dealing e.g. subscription, conversion | Details | Price per unit (if applicable) |
4. OTHER INFORMATION
(a) Indemnity and other dealing arrangements
| Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer: Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state none |
(b) Agreements, arrangements or understandings relating to options or derivatives
| Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to: (i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced: If there are no such agreements, arrangements or understandings, state none |
(c) Attachments
| Is a Supplemental Form 8 (Open Positions) attached? | NO | ||
| Date of disclosure: | 26 Oct 2015 | ||
| Contact name: | RAJESH MUTHANNA | ||
| Telephone number: | 020 3555 4634 |
Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panels Market Surveillance Unit is available for consultation in relation to the Codes disclosure requirements on +44 (0)20 7638 0129.
The Code can be viewed on the Panels website at www.thetakeoverpanel.org.uk.
View source version on businesswire.com: http://www.businesswire.com/news/home/20151026005902/en/
BARCLAYS PLC
Recent news on Steris
See all newsREG - Travelex Financing - Update on debt restructuring
AnnouncementREG - Synergy Health Steris Corp. - Scheme Effective <Origin Href="QuoteRef">STE.N</Origin> <Origin Href="QuoteRef">SYR.L</Origin>
AnnouncementREG - State Street Global Steris Corp. Synergy Health - Form 8.3 - Steris Corporation <Origin Href="QuoteRef">STE.N</Origin> <Origin Href="QuoteRef">SYR.L</Origin>
AnnouncementREG - Legal&Gen Inv Mgmnt Synergy Health Steris Corp. - Form 8.3 - Steris Corporation <Origin Href="QuoteRef">STE.N</Origin> <Origin Href="QuoteRef">SYR.L</Origin>
AnnouncementREG-BARCLAYS PLC FORM 8.3 - STERIS CORPORATION <Origin Href="QuoteRef">BARC.L</Origin> <Origin Href="QuoteRef">STE.N</Origin>
Announcement